M. Piccart

发表论文 28 篇 · 总被引 1301 次 · h-index 15

代表论文

3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3) (2016 · Annals of Oncology · 被引 519)
PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab. (2016 · Annals of Oncology · 被引 140)
Immunotherapy for early breast cancer: too soon, too superficial, or just right? (2020 · Annals of Oncology · 被引 98)
Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO). (2014 · Annals of Oncology · 被引 95)
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS). (2017 · Annals of Oncology · 被引 84)
Discrepancies in cancer incidence and mortality and its relationship to health expenditure in the 27 European Union member states. (2013 · Annals of Oncology · 被引 73)